🇺🇸 FDA
Pipeline program

Placebo Oral Tablet

MPH966-2-01

Phase 2 small_molecule completed

Quick answer

Placebo Oral Tablet for Alpha 1-Antitrypsin Deficiency is a Phase 2 program (small_molecule) at Mereo BioPharma Group plc with 1 ClinicalTrials.gov record(s).

Program details

Company
Mereo BioPharma Group plc
Indication
Alpha 1-Antitrypsin Deficiency
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials